CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing

Detalles Bibliográficos
Autores principales: Suwa, Michihiro, Nohara, Yuki, Morii, Isao, Kino, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483109/
https://www.ncbi.nlm.nih.gov/pubmed/37693231
http://dx.doi.org/10.1253/circrep.CR-66-0012
_version_ 1785102308454957056
author Suwa, Michihiro
Nohara, Yuki
Morii, Isao
Kino, Masaya
author_facet Suwa, Michihiro
Nohara, Yuki
Morii, Isao
Kino, Masaya
author_sort Suwa, Michihiro
collection PubMed
description
format Online
Article
Text
id pubmed-10483109
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Circulation Society
record_format MEDLINE/PubMed
spelling pubmed-104831092023-09-08 CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing Suwa, Michihiro Nohara, Yuki Morii, Isao Kino, Masaya Circ Rep Corrigendum The Japanese Circulation Society 2023-09-08 /pmc/articles/PMC10483109/ /pubmed/37693231 http://dx.doi.org/10.1253/circrep.CR-66-0012 Text en Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
spellingShingle Corrigendum
Suwa, Michihiro
Nohara, Yuki
Morii, Isao
Kino, Masaya
CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title_full CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title_fullStr CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title_full_unstemmed CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title_short CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
title_sort corrigendum: safety and efficacy re-evaluation of edoxaban and rivaroxaban dosing with plasma concentration monitoring in non-valvular atrial fibrillation: with observations of on-label and off-label dosing
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483109/
https://www.ncbi.nlm.nih.gov/pubmed/37693231
http://dx.doi.org/10.1253/circrep.CR-66-0012
work_keys_str_mv AT suwamichihiro corrigendumsafetyandefficacyreevaluationofedoxabanandrivaroxabandosingwithplasmaconcentrationmonitoringinnonvalvularatrialfibrillationwithobservationsofonlabelandofflabeldosing
AT noharayuki corrigendumsafetyandefficacyreevaluationofedoxabanandrivaroxabandosingwithplasmaconcentrationmonitoringinnonvalvularatrialfibrillationwithobservationsofonlabelandofflabeldosing
AT moriiisao corrigendumsafetyandefficacyreevaluationofedoxabanandrivaroxabandosingwithplasmaconcentrationmonitoringinnonvalvularatrialfibrillationwithobservationsofonlabelandofflabeldosing
AT kinomasaya corrigendumsafetyandefficacyreevaluationofedoxabanandrivaroxabandosingwithplasmaconcentrationmonitoringinnonvalvularatrialfibrillationwithobservationsofonlabelandofflabeldosing

Ejemplares similares